163 related articles for article (PubMed ID: 37920431)
21. Developing and validating a survival prediction model based on blood exosomal ceRNA network in patients with PAAD.
Wang S; Xu L; Zhu K; Zhu H; Zhang D; Wang C; Wang Q
BMC Med Genomics; 2022 Dec; 15(1):260. PubMed ID: 36522691
[TBL] [Abstract][Full Text] [Related]
22. Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making.
Zhu J; Shi Y; Lan S; Wang J; Jiang F; Tang C; Cai Y; Pan Z; Jian H; Fang H; Zhang Y; Zhong F
Apoptosis; 2023 Jun; 28(5-6):769-782. PubMed ID: 36882663
[TBL] [Abstract][Full Text] [Related]
23. TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer.
Zou X; Guo Y; Mo Z
Front Genet; 2022; 13():905988. PubMed ID: 36419829
[No Abstract] [Full Text] [Related]
24. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
25. Identification of Potential Genomic Alterations and the circRNA-miRNA-mRNA Regulatory Network in Primary and Recurrent Synovial Sarcomas.
Yao Q; He YL; Wang N; Dong SS; Tu He Ta Mi Shi ME; Feng X; Chen H; Pang LJ; Zou H; Zhou WH; Li F; Qi Y
Front Mol Biosci; 2021; 8():707151. PubMed ID: 34485383
[No Abstract] [Full Text] [Related]
26. COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma.
Xu Q; Zheng J; Su Z; Chen B; Gu S
BMC Gastroenterol; 2023 Nov; 23(1):397. PubMed ID: 37974070
[TBL] [Abstract][Full Text] [Related]
27. A pan-cancer analysis revealing the role of LFNG, MFNG and RFNG in tumor prognosis and microenvironment.
Gong X; Zheng C; Jia H; Liu Y; Yang R; Chen Z; Pan Y; Li X; Liu Y
BMC Cancer; 2023 Nov; 23(1):1065. PubMed ID: 37932706
[TBL] [Abstract][Full Text] [Related]
28. LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
Li T; Zhao H; Zhou H; Geng T
PLoS One; 2021; 16(3):e0247817. PubMed ID: 33661995
[TBL] [Abstract][Full Text] [Related]
29. The potential use and experimental validation of genomic instability-related lncRNA in pancreatic carcinoma.
Xia X; Zhao S; Song X; Zhang M; Zhu X; Li C; Chen W; Zhao D
Medicine (Baltimore); 2023 Sep; 102(37):e35300. PubMed ID: 37713870
[TBL] [Abstract][Full Text] [Related]
30. KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma.
Li Y; Su Z; Wei B; Liang Z
Int J Gen Med; 2021; 14():2677-2694. PubMed ID: 34188523
[TBL] [Abstract][Full Text] [Related]
31. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
[TBL] [Abstract][Full Text] [Related]
32. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
Yan C; Niu Y; Li F; Zhao W; Ma L
J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value and the Immune Microenvironment-associated Role of
Song Y; Wang Y; Yu T; He Y; Wang C; Wang F; Zhou Y
Anticancer Res; 2023 Dec; 43(12):5393-5408. PubMed ID: 38030175
[TBL] [Abstract][Full Text] [Related]
34. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma.
Zhang Z; Shang J; Dai Z; Yao Y; Shi Y; Zhong D; Liang Y; Lai C; Yang Q; Feng T; Huang X
Front Genet; 2022; 13():848391. PubMed ID: 35601487
[No Abstract] [Full Text] [Related]
35. The NT5DC family: expression profile and prognostic value in pancreatic adenocarcinoma.
Yu X; Sun R; Yang X; He X; Guo H; Ou C
J Cancer; 2023; 14(12):2274-2288. PubMed ID: 37576396
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma.
Huang J; Chen Z; Ding C; Lin S; Wan D; Ren K
Front Oncol; 2021; 11():711402. PubMed ID: 34497764
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive Analysis of circRNA-miRNA-mRNA Regulatory Network and Novel Potential Biomarkers in Acute Myocardial Infarction.
Wu J; Li C; Lei Z; Cai H; Hu Y; Zhu Y; Zhang T; Zhu H; Cao J; Hu X
Front Cardiovasc Med; 2022; 9():850991. PubMed ID: 35872921
[TBL] [Abstract][Full Text] [Related]
38. System Analysis Based on Pancreatic Cancer Progression Identifies BRINP2 as a Novel Prognostic Biomarker.
Kang Y; Xu X; Liu J
Crit Rev Eukaryot Gene Expr; 2023; 33(7):1-16. PubMed ID: 37602449
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients.
Cui Z; Du L; Wang J; Li Z; Xu J; Ou S; Li D; Li S; Hu H; Chen G; Wu Z
BMC Cancer; 2022 Dec; 22(1):1354. PubMed ID: 36572856
[TBL] [Abstract][Full Text] [Related]
40. PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer.
Chen C; Shang A; Gao Y; Huang J; Liu G; Cho WC; Li D
Front Mol Biosci; 2022; 9():968458. PubMed ID: 36203873
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
